A REVIEW OF DOPING IN SPORTS: INDIA AND THE WORLD

1. INTRODUCTION

Sports encompass a diverse array of physical pursuits aimed at elevating not only physical fitness and mental well-being but also forging social bonds and attaining triumphs in the arena of competition. Engaging in sports, whether informally or within the structured frameworks of organized sports, wields the remarkable power to sculpt the very core of one's character, particularly when it comes to the most competitive levels of play. Professionals and athletes in their respective sports are frequently challenged to perform at their best. The impetuses driving this unwavering commitment span a spectrum, ranging from individual pride and national prestige to the ascent of one's career trajectory. In professional sports, circumstances often arise where athletes need to surpass their body's ordinary limits to gain a competitive advantage. In contact sports, setbacks like injuries need proper attention before participating in events. This pursuit entails harnessing one's physiological potential to the utmost, sometimes steering individuals towards the employment of banned substances or ethically questionable methods, all with the intent of amplifying performance or expediting recovery from injuries. In Beckmann's sports dictionary, the term "doping" is defined as the utilization of substances that enhance performance, resulting in the athlete achieving a higher level of capability than they would typically attain.1

The first official definition was propounded by the European Committee Council in 1963, which stated, “Doping represents the use of substances or physiological mediators, which are not normally present in the human body, introduced as an external aid to increase the athletes’ performance during a competition.”2

In 1999, the International Olympic Committee (IOC) established the World Anti-Doping Agency (WADA) in Lausanne, Switzerland. WADA's mission revolves around fostering, coordinating, and overseeing the battle against substance abuse in sports. It has played an engaged role in shaping regulations and offering directives concerning prohibited substances within the realm of professional sports. Additionally, WADA has introduced mandatory testing through random sampling methods during competitive sports. Mirroring the principles of WADA, India instituted the National Anti-Doping Agency (NADA) to address similar concerns at a national level.

2. HISTORY OF DOPING AND ITS EVOLUTION

Doping has been a widespread practice throughout history, with instances dating back to ancient times. In Norwegian mythology, Bufotenin, a substance found in frog skin or certain species of Amanita mushrooms, was mentioned as a substance that could enhance physical strength.3 During Ancient Greek times, experts provided athletes with different substances to enhance their physical abilities. This was widely accepted, and there is no concrete evidence to dispute the notion that these prohibited substances were explicitly banned. Likewise, during the Roman Empire, there are references to gladiators using substances to enhance their strength. Even racing horses were administered various mixtures of substances intended to boost their speed and endurance.4 The first instance of the dangers of doping in modern sports occurred when Tom Hicks passed away due to consuming a combination of cognac and strychnine during the Saint Louis marathon in 1904. In 1928, the International Athletics Federation (IAF) took the pioneering step of prohibiting doping in athletic competitions. Subsequently, anti-doping testing was implemented in 1960.5

In India, doping in sports started on a large scale prior to the 1982 Asiad Games. With India as the host nation, the pursuit of medals evolved into a matter of elevated status. At the forefront of endorsing drug misuse were the Bulgarian weightlifting mentors. They openly furnished Indian lifters with hazardous substances. However, doping's influence extended beyond weightlifting, infiltrating the realm of athletics. Major (retd.) Joginder Singh, a two-time Asian gold medalist intricately involved in the '82 Asiad team's training, noted how Indian athletes during the 1982 games passionately embraced drug use in their training camps. At that juncture, jests circulated that these athletes were smashing records fueled by substantial drug consumption, all while evading scrutiny. Astonishingly, it wasn't until the year 2000 that the initial significant incident came to light. The push for Olympic doping tests gained momentum. The 1972 Olympic Games in Munich marked the inaugural instance of formal supervision over conventional substances. Anabolic steroids were the pioneering substances subjected to control during the 1976 Olympics in Montreal, leading to disqualifications and forfeiture of medals for numerous athletes. These developments prompted the International Olympic Committee (IOC) to declare that doping test results must be publicly disclosed during the competitions.6 In the 1980s, fueled by scientific and technological advancements, novel methods emerged to trigger doping in sports. The Anti-Doping campaign surged as controls extended beyond competitions. The Olympic Games experienced their inaugural high-profile doping controversy with Ben Johnson, the renowned Canadian 100m sprinter hailed as the world's fastest man, facing a two-year suspension for testing positive for anabolic steroids.7 Doping was employed as a means to achieve global acknowledgment for the Communist-led administration of East Germany (GDR - German Democratic Republic). Under a tightly structured framework, founded on the principles of secrecy, substances were systematically provided to athletes throughout the country. Following the fall of the Iron Curtain, revelations of systematic doping practices in the GDR came to light. The pursuit of medals and the unethical exploitation of sports as a propaganda tool for national superiority had allowed anti-doping efforts to progress, often disregarding athletes' health and well-being.

3.1. Erythropoietin (EPO) 8

Erythropoietin (EPO), a natural peptide hormone, originates in the human body, primarily from the kidneys. It prompts the bone marrow to elevate red blood cell production. Athletes use EPO injections to raise red blood cell count and thus enhance aerobic capacity. However, misusing EPO poses significant health hazards, including thickening of the blood that escalates the risk of fatal conditions like heart disease and stroke. EPO has also been associated with athlete fatalities.

3.2. CERA 9

CERA, an advanced version of EPO known as Continuous Erythropoiesis Receptor Activator, represents the third generation. Due to its extended half-life, CERA requires less frequent administration. Athletes employ CERA not only for quicker recovery but also to elevate their oxygen-carrying capacity, thus enhancing endurance.

3.3. ANABOLIC STEROIDS 10

Anabolic steroids mimic testosterone, a hormone produced in the male testes and, to a lesser extent, in female ovaries. Elevating their levels in the bloodstream aids athletes in augmenting muscle size and strength, while purportedly reducing body fat and post-injury recovery time. These steroids can also trigger aggression, along with causing issues such as high blood pressure, acne, liver function abnormalities, menstrual cycle disruptions, reduced sperm production, male impotence, kidney failure, and heart disease. Notable examples encompass testosterone, stanozolol, boldenone, nandrolone, and clostebol.

3.4. HUMAN GROWTH HORMONE 11

Human growth hormone (hGH), also known as somatotropin or somatotrophic hormone, is a naturally occurring hormone produced and released by cells in the anterior pituitary gland situated at the brain's base. hGH's primary function in body growth is to stimulate the liver and other tissues to produce insulin-like growth factor IGF-1, which spurs the generation of cartilage cells, leading to bone growth. This hormone also significantly impacts muscle and organ growth, thereby enhancing athletic performance. Notable reported side effects of hGH misuse include diabetes in susceptible individuals, exacerbation of heart conditions, muscle and joint discomfort, hypertension, cardiac issues, abnormal organ growth, and accelerated osteoarthritis.

3.5. DIURETICS 12

Diuretics are frequently employed as a cover to hide other prohibited substances, but they also aid athletes in shedding weight. This can be potentially advantageous in sports that require specific weight categories for qualification, such as boxing and weightlifting. This type of doping is widespread in these disciplines. Commonly used diuretics include furosemide, bendroflumethiazide, and metolazone.

3.6. BLOOD DOPING 13

Blood doping is categorized into two types: autologous and homologous. Autologous blood doping involves transfusing one's own stored, refrigerated, or frozen blood. Homologous blood doping entails transfusing blood from another person with the same blood type. With the advent of effective EPO detection methods, there has been a recent resurgence in blood transfusion-based doping. A homologous blood transfusion test was introduced during the 2004 Athens Olympic Games. The World Anti-Doping Agency (WADA) leads in developing "biological passports" that track an athlete's blood and biological data over time. Moreover, WADA funds research to devise a test for autologous transfusions.

3.7. INSULIN 14

Insulin heightens muscle glucose uptake and supports muscle glycogen formation and storage. Athletes might utilize it for endurance-demanding events. It is also abused alongside growth hormones or anabolic steroids to enhance muscle growth. Misuse causes severe hypoglycemia, resulting in cognitive impairment, seizures, unconsciousness, and in severe cases, brain damage or death.

3.8. GENE DOPING 15

WADA defines gene doping as the introduction of nucleic acids or sequences, along with normal or altered cells. Medical gene therapy's progress has opened doors for potential cheaters to genetically enhance physical abilities. Though practical instances are uncertain, gene doping theoretically could amplify muscle growth, blood production, endurance, oxygen distribution, and pain tolerance. Presently, no tests can detect gene doping.

4. CASES OF DOPING - INDIA AND THE WORLD .

4.1. East Germany systematic doping – the 1970s and 1980s 16

In pursuit of demonstrating communism's superiority, the East German government opted to administer athletes with performance-enhancing substances, primarily steroids. Athletes observed bodily changes but had little autonomy within an authoritarian system. Suspicions arose when the East Germany women's swimming team secured 11 out of 13 medals in the 1976 Montreal Olympics. It was later revealed that there was a systemic doping program involving around 9,000 athletes. While those responsible were tried and convicted, athletes suffered lifelong health issues like cancer and infertility as a consequence of the doping scheme.

4.2. Ben Johnson – 1988

During the 1988 Seoul Olympics, Canadian sprinter Ben Johnson clinched gold in the 100m, setting a new world record and outperforming his American rival, Carl Lewis. Subsequent testing detected the steroid stanozolol in Johnson's system, leading him to relinquish his gold medal to Lewis. After failing another drug test in 1993, Johnson received a lifetime suspension. His case shed light on the widespread use of doping beyond the Communist bloc, spanning the entire athletics realm.

4.3. Diego Maradona - 1994

Diego Maradona, the celebrated Argentine soccer icon, who led his team to triumph in the 1986 World Cup, tested positive for five distinct ephedrine variants during the 1994 World Cup. He had previously faced a 15-month suspension in 1991-92 due to cocaine use. Despite his dedication, losing 26 pounds to prepare for the World Cup and showcasing his skills with a goal and assist in the opening round, Maradona's career came to a halt following this incident. Although he played on for a few more years, he never represented Argentina again.

4.4. The Festina Affair – 1998 17

During a border inspection near Belgium, specifically in Lille, a French town, authorities uncovered a collection of performance-enhancing substances, including amphetamines, erythropoietin, and steroids, constituting the Festina Affair. This scandal unfolded amidst and following the 1998 Tour De France, tainting professional cycling. Subsequent police inquiries led the team's manager and doctor to confess to the doping regimen. As a result, the team was ultimately ejected from the race. This controversy notably contributed to the establishment of the World Anti-Doping Agency in 1999, shaping the landscape of anti-doping efforts.

4.5. Seema Punia – 2000

Seema Punia, dubbed the "millennium child," marked India's initial prominent doping case. The discus thrower secured gold at the 2000 World Junior Championships in Chile, only to lose the medal due to a positive test for the stimulant pseudoephedrine. Given the absence of established regulations at the time, she received a warning and evaded a ban. Despite this setback, Punia rebounded impressively, clinching podium finishes in subsequent Commonwealth and Asian Games in the following decades.

4.6. Andreas Krieger 18

Heidi Krieger, a former East German female shot-putter, was subjected to systematic anabolic steroid doping by East German officials in the 1980s and 1990s. The doping started at age 16, resulting in visible male attributes by the time she was 18. In 1997, Krieger underwent gender confirmation surgery and changed the name to Andreas. This case garnered significant attention, prompting other athletes to publicly address the doping legacy in East Germany for the first time.

4.7. Lance Armstrong - 2012

Lance Armstrong, the American cyclist, clinched seven consecutive Tour de France victories from 1999 to 2005. His triumphs brought him fame, which was further elevated by his survival of cancer. Despite suspicions of steroid use, no conclusive evidence emerged. In 2012, the U.S. Anti-Doping Agency accused Armstrong of using performance-enhancing substances. He chose not to challenge the charges, resulting in the forfeiture of his Tour de France titles and a cycling ban. In October, the agency issued a report labeling Armstrong as part of "the most sophisticated, professionalized and successful doping program that sport has ever seen."

4.8. Indian Weightlifters Ban – 2015

One of the nation's most significant doping controversies unfolded as the Indian Weightlifting Federation temporarily suspended 21 weightlifters due to their positive tests for prohibited substances across multiple events. In the same year, Punjabi thrower Ketki Sethi faced an eight-year ban following her second positive doping test during a national meet in Patiala, transpiring within a brief time frame.

4.9. Prithvi Shaw – 2019 19

Star Indian cricketer Prithvi Shaw faced an eight-month suspension upon testing positive for terbutaline, a banned substance present in cough syrups. Similarly, another Indian cricketer, Yusuf Pathan, received a five-month ban after testing positive for terbutaline during a domestic match in 2017. These incidents prompted the BCCI to intensify its anti-doping efforts, focusing on awareness and control. Notably, the Prithvi Shaw case triggered a sequence of events leading to the BCCI's shift in stance, eventually aligning with WADA's regulations.

4.10. Russia Olympic Ban 2021-2022

In 2016, the former head of Moscow's anti-doping lab publicly exposed a government-led effort to supply Russian athletes with performance-enhancing drugs and mask their usage during the 2014 Sochi Olympics. By December 2019, due to manipulated reports from the Moscow lab, WADA imposed a four-year suspension on Russia for major sports events, which was later reduced to two years by the Court of Arbitration for Sport in 2020. Russian athletes were allowed to participate in the 2021 and 2022 Olympics, though not under the Russian flag or anthem.

5. ANTI-DOPING ORGANISATIONS: THE LEGAL FRAMEWORK

5.1. WADA 20

WADA, established in 1999 following the Festina Scandal, is a prominent global independent body that spearheads the battle against doping in sports. Endorsed by the International Olympic Committee, WADA is tasked with coordinating, regulating, and overseeing anti-doping efforts. It is financed by both international sports bodies and governments. WADA’s pursuits encompass scientific research, education, capacity building, and ensuring adherence to the World Anti-Doping Code. The overarching goal is to unify anti-doping rules across sports and nations, annually cataloging banned substances and methods for athletes.

5.2. UNESCO - International Convention Against Doping in Sports 21

Crafted in 2003 and ratified in 2005 (implemented in 2007), UNESCO's International Convention Against Doping in Sport stands as a cornerstone of global athletic integrity. This seminal agreement orchestrates cohesion among guidelines, regulations, and anti-doping laws, ushering athletes into a realm of parity and justice. Flexibility resonates within its core, empowering governments to enact its tenets. By embracing anti-doping research, nurturing education initiatives, and fortifying doping controls, member states pledge allegiance to the spirit of sport. Through this convention, a symphony of international cooperation resounds, safeguarding athletes and preserving sports' noble ethos. Not merely a gesture, this framework breathes life into the World Anti-Doping Code, bestowing governments with jurisdiction to confront doping's nuanced challenges. Beyond the stadium lights, the convention’s reach unfurls, encapsulating a pledge for enduring fairness in the realm of athletics.

5.3. Court of Arbitration for Sports (CAS) 22

In 1984, the Court of Arbitration for Sport found its headquarters in Lausanne, Switzerland. By adhering to the 2009 World Anti-Doping Code, all signatories, spanning from Olympic federations to national committees, conceded to CAS jurisdiction for anti-doping infractions. In 2016, CAS judges, versed in Olympic doping cases, took the reins from the IOC disciplinary commission, fortifying the fight for fair competition.

5.4. NADA 23

Established in 2009, the National Anti-Doping Agency (NADA) takes the helm in India's battle for clean sports. Tasked with orchestrating, overseeing, and fostering doping control initiatives, NADA aligns its strategies with the global edicts of the World Anti-Doping Agency. It stands not only as an enforcer but also as an educator, harmonizing with fellow anti-doping bodies and kindling research and awareness. Empowered by the Union Government, NADA's collective includes scientific minds and Indian Olympic Association representatives, united not only to sanction but also to enlighten, ensuring athletes are conscious of inadvertent prohibited substance use.

6. EMPOWERING CLEAN SPORTS: INDIA'S NATIONAL ANTI-DOPING BILL, 2022

In a landmark move, India joined the ranks of nations with its own anti-doping legislation in August of last year. Designed to curb doping, the bill forbids athletes and support personnel from engaging in doping practices. Crucially, it lends legal authority to bodies like the National Anti-Doping Agency (NADA) and the National Dope Testing Laboratory (NDTL)24, enabling the expansion of testing facilities.

Alarming statistics underscore the gravity of doping in India. In 2019, over 150 athletes failed doping tests, with bodybuilders constituting a significant portion. Notably, India ranked third globally for doping violations in 2021, trailing only Russia and Iran25. High-profile incidents, like Commonwealth Games hopeful Aishwarya Babu's recent test failure, emphasize the pressing need for stringent measures.

The bill aspires to provide timely justice to athletes while fostering collaboration among agencies in the fight against doping. It exemplifies India's commitment to international clean sports standards and establishes an independent anti-doping adjudication mechanism. A National Board for Anti-Doping in Sports will oversee regulation and compliance, ensuring the agency's effectiveness. Existing infrastructure, like the National Dope Testing Laboratory, will be pivotal, and new testing facilities might emerge under central government guidance.

7. ANTI-DOPING IN INDIA: ISSUES AND CHALLENGES

7.1. Instances of Violations against Anti-Doping Regulations

NADA has conducted rigorous testing on more than 40,000 athletes, aiming to uncover breaches of anti-doping regulations. This effort has led to the identification of 1206 athletes who, according to NADA guidelines, have transgressed these rules. India's consistent unfavorable rankings in Anti-Doping Regulation Breaches (ADRBs), as documented by WADA, underline its ongoing challenges. In 2018, Russia (144 ADRBs), Italy (132 ADRBs), and France (114 ADRBs) secured the top positions in doping violations, with India closely trailing in fourth place with 107 ADRBs. Reflecting on 2017, India held responsibility for the fourth-highest count of ADRBs (57), while for the preceding three years (2015-2017), India consistently ranked third in ADRBs. Unwillingness or inability to provide a sample resulted in numerous athletes violating NADA Regulations. Despite the absence of comprehensive empirical evidence regarding unintentional doping's scope in India, prevalent anecdotal accounts and commentary strongly highlight its widespread nature. This is often linked to a lack of awareness or the inadvertent consumption of banned substances through nutritional supplements or medications.

7.2. Unveiling India's Dwindling Testing Trends

In August 2019, NDTL's WADA accreditation was suspended due to non-compliance with the ISL and its technical documents, forcing all dope tests to be evaluated abroad, and incurring significant expenses for NADA. This was particularly burdensome given India's large population. However, the testing results were inadequate. Strangely, the number of athletes tested by NADA dropped notably from 5,162 samples in 2015 to 2,831 samples in 2016, even though 2016 was an Olympic year. Over time, athlete testing increased, reaching 4,004 samples in 2019. Yet, the COVID-19 outbreak in 2020 severely hampered testing efforts, with only 1,186 tests conducted throughout the year. Consequently, the percentage of athletes with positive adverse analytical findings (AAFs) surged, contrasting sharply with the global average. In 2019, the positive AAF rate was 5.6%, escalating to 4.6% in 2020. The apparent connection between reduced testing frequency in India, the rise in AAF percentages, and a decline in athletes testing positive for banned substances may suggest a complex situation. It could actually signify a higher likelihood of athletes evading detection.

7.3. Unveiling NDTL's Suspension and Flawed Testing Practices

The National Dope Testing Laboratory (NDTL) in New Delhi suffered a significant setback when WADA suspended its accreditation in August 2019 due to consistent failure in aligning testing procedures with the International Standard for Laboratories (ISL). Despite repeated warnings, NDTL's failure to rectify its practices led to this downfall. An independent disciplinary committee's recommendations highlighted substantial non-compliance with ISL standards, leading to the suspension. NDTL's isotope ratio mass spectrometry (IRMS) sampling method faced particular objections. Inadequate standard operating procedures and a poorly managed quality control team further exacerbated the issues. A stark example highlighted the issue: six tests initially labeled as negative Adverse Analytical Findings (AAFs) were retested at a WADA-accredited lab in Montreal, revealing positive results. This led to suspensions for six Indian athletes, showcasing NDTL's deficiencies. False positives worsened the situation, causing unjust suspensions.

7.4. Anti-Doping Disputes In the context of anti-doping disputes, procedural issues are a significant concern. The Anti-Doping Disciplinary Panel (ADDP) has faced criticism for issuing flawed decisions multiple times. A consistent pattern emerges as both ADDP and ADAP consistently hand down four-year penalties to athletes who test positive for specific substances outside of competitions. Interestingly, this type of Anti-Doping Rule Violation (ADRV) typically carries a maximum suspension of two years. However, NADA can extend this term if it can prove that the athlete intentionally used the banned substance for performance enhancement. These inconsistencies in rule interpretation are not limited to India, but extend internationally. The Anti-Doping Code outlines minimum procedural safeguards, including an athlete's right to a fair, impartial, and independent hearing, access to legal representation, a cost-effective and accessible hearing process, and timely conflict resolution. In contrast, countries like the UK and New Zealand have consistently updated their sports dispute resolution procedures, while India has yet to do so. Although many athletes have the right to appeal to the CAS, Indian athletes rarely exercise this right. Surprisingly, out of 1206 recorded ADRVs in India, only 14 cases have reached the CAS. Strikingly, all but one of these instances were initiated by WADA's appeals. This situation has led to claims that the fact that only one Indian athlete has sought recourse at the CAS could be seen as evidence of issues with access to justice in the anti-doping dispute resolution framework.

7.5. Inadvertent Doping and Education: A Crucial Nexus

In sports, the shadow of inadvertent doping looms over athlete integrity and competition purity. A 2022 Indian study exposed a pivotal facet of this issue, highlighting the vital link between education and inadvertent doping. Focused on elite athletes, the study examined how anti-doping education influenced awareness and conduct. Surprisingly, only 38.1% of the 181 surveyed athletes engaged in anti-doping education sessions by NADA or their federations, held in training camps or institutes. These sessions aimed to cultivate a profound comprehension of doping risks. This mosaic of insights unveiled a stark distinction between informed athletes and those oblivious to doping intricacies. A significant 67.4% of respondents displayed familiarity with NADA and WADA, yet only superficially. Moreover, 53.6% exhibited fragmented awareness of anti-doping suspension consequences—hinting at comprehension without grasping the gravity. The study's zenith showcased a contrast between athletes attending anti-doping education and those abstaining. Attendees reported amplified understanding of doping risks—a transformative enlightenment beyond competition. It underlines education's power. In a realm of split-second decisions and athleticism, the line between inadvertent and intentional misconduct is thin. The findings demand a paradigm shift—prioritizing anti-doping education for athletes. Education must become a fundamental pillar, not a choice. Amid the complexities of fair play, this study echoes: knowledge thwarts inadvertent doping; a rallying call to embolden athletes, fortify integrity, and elevate sportsmanship.

8. ADDRESSING SHORTCOMINGS IN THE NATIONAL ANTI-DOPING BILL

The National Anti-Doping Bill of 2021 is a crucial step towards maintaining the integrity of sports and upholding the principles set forth by the World Anti-Doping Agency (WADA). However, a comprehensive analysis reveals certain shortcomings that need immediate attention to ensure the effectiveness of the bill.

8.1. Safeguarding NADA Autonomy

One of the cornerstones of effective National Anti-Doping Organizations (NADOs) is their autonomy from external influences. As per WADA guidelines, NADOs are entrusted with the responsibility of preserving the purity of sports through rigorous adherence to anti-doping regulations. Nevertheless, the provisions within the National Anti-Doping Bill 2021 may fall short in safeguarding the independence of the National Anti-Doping Agency (NADA) from potential pressures, both from the central government and national sports organizations. This vulnerability threatens the impartiality of NADA's functions, including athlete testing, violation evaluations, and penalty imposition under the WADA Code.

8.2. Transparent Qualifications for Director General

Another aspect that requires attention pertains to the qualifications and appointment of the Director General of NADA. While the Bill designates that the central government will appoint the Director General, it lacks clarity regarding the specific qualifications and experience necessary for this pivotal role. The omission of these qualifications within the Bill itself necessitates further elaboration through subsequent Rules. By explicitly defining these prerequisites, the government can ensure a transparent and merit-based selection process for this significant position.

8.3. Ensuring Director General's Independence

An issue of concern arises from the central government's authority to remove the Director General based on reasons of misconduct, incapacity, or unspecified grounds. The ambiguity surrounding the latter category not only raises questions about the criteria for removal but also grants considerable discretion to the central government. This discretion, coupled with the lack of specification, could potentially compromise the Director General's independence. Stricter guidelines within the Bill are essential to prevent undue interference and maintain the agency's integrity.

8.4. Clarifying the Role of Vice-Chairpersons

To maintain consistency and clarity within the structure of the National Board for Anti-Doping in Sports, a specific concern needs to be addressed. The composition of the Disciplinary Panel, responsible for determining consequences for anti-doping rule violations, includes a Chairperson, four Vice-Chairpersons, and ten members. However, the Bill fails to specify which of the four Vice-Chairpersons will assume responsibility for forming hearing panels in the absence of the Chairperson. Clear designation of this role is vital to ensure smooth proceedings and effective decision-making.

8.5. Expertise in Disciplinary and Hearing Panels

The composition of the hearing panel is pivotal for fair evaluations of anti-doping violations. WADA guidelines underscore the importance of collective expertise in legal matters, science, medicine, and sport, alongside anti-doping experience. Regrettably, the Bill falls short in mandating anti-doping experience for members of the hearing panels. Incorporating this requirement would enhance the panel's credibility and effectiveness in upholding anti-doping regulations

8.6. Criteria for Dismissal of Disciplinary and Hearing Panel Members

In accordance with WADA directives, a fair process for addressing anti-doping rule violations is mandated. This requires hearing panel members to serve their full term, except for valid reasons such as legal incapacity, involvement in doping or criminal activities, or failure in prescribed duties.

The proposed Bill establishes the National Board for Anti-Doping in Sports, which includes a Disciplinary Panel for handling rule violations and an Appeal Panel for reviewing decisions. The Board has the authority to remove members from both panels based on specified grounds, although these criteria are not detailed in the Bill. This discretion could potentially affect the panels' independent functioning. While the Bill outlines grounds for removal of National Board members (such as conviction and misuse of position) and their hearing rights, it lacks a similar provision for members of the Disciplinary and Appeal Panels.

9. SUGGESTIONS TO IMPROVE ANTI-DOPING SCENARIO

9.1. Ensuring the Autonomy of National Anti-Doping Organizations

The autonomy of NADOs serves as a safeguard against the specter of external influences that might compromise the integrity of anti-doping endeavors. Financial, political, and commercial pressures can encroach on the pursuit of unbiased and effective anti-doping strategies. By ensuring NADOs' independence, we insulate them from such pressures, empowering them to make decisions rooted solely in the interests of protecting athletes' health and upholding the sanctity of sports.

9.2. Revamped Anti-Doping Testing Strategies Elevating the landscape of testing protocols against doping in India necessitates a comprehensive and collaborative approach, engaging an array of stakeholders: sports entities, governmental bodies, athletes, and the scientific community. To effectively combat this issue, a multifaceted strategy involving advanced medical techniques, state-of-the-art technology, and ingenious methodologies is imperative. Presently, the exigency demands substantial investments in contemporary doping control laboratories, equipped with cutting-edge apparatus and technology to yield testing that is not only more precise but also more efficient. This endeavor should emphasize adherence to global benchmarks, obtaining accreditation from entities like WADA to ensure international standards are met. Embracing avant-garde analytical techniques, including mass spectrometry and gas chromatography will empower the identification of even the faintest traces of illicit substances. A holistic Athlete Biological Passport (ABP) initiative, meticulously tracing an athlete's biological indicators over time encompassing blood and urine profiles, stands as a pivotal tool to unearth anomalies hinting at potential doping. The ABP system should be a dynamic entity, undergoing periodic enhancements in line with emerging scientific insights. Fostering global partnerships with anti-doping agencies and research institutions is paramount; the synergy facilitates the exchange of knowledge, optimal methodologies, and resource optimization. Participation in international proficiency tests serves as a litmus test for the precision and reliability of testing methodologies. Investment in pioneering research geared towards devising novel approaches for the identification of nascent doping agents and methodologies is non-negotiable. Vigilance regarding advancements in anti-doping science should drive regular refinements in the testing protocols, keeping the methods at the vanguard of scientific progress.

9.3. Stricter Penalties that are Consistent across all Jurisdictions

Implementing stricter penalties that are consistent across all jurisdictions within the guidelines of the World Anti-Doping Agency (WADA) can be an effective strategy to combat anti-doping violations in sports.

A tiered system of penalties based on the severity of the doping violation can be implemented. For example: Tier 1 would cover minor violations with unintentional substance use, Tier 2 would address significant violations with intentional substance use, and Tier 3 would include aggravated violations involving multiple substances or systematic doping schemes. Consistency in sanctions is crucial. Ensuring that penalties are consistent across all jurisdictions can prevent athletes from seeking lenient jurisdictions for reduced penalties. This also prevents the Anti-Doping Disciplinary Panel from making erroneous decisions.

9.4. Improved Whistleblower Mechanism

Implementing robust measures can establish a comprehensive whistleblower framework aimed at fostering a culture of reporting pertinent information to effectively counter instances of anti-doping violations. These measures encompass various essential aspects: Firstly, prioritizing Anonymity Protection entails setting up secure and confidential channels that allow individuals to submit valuable information about doping violations without revealing their identities. Secondly, ensuring Legal Protection becomes vital in safeguarding whistleblowers from any form of retaliation or harassment, both within and outside the sports community. To ensure the credibility of the system, the establishment of Independent Oversight plays a pivotal role. This entails creating an impartial body or organization responsible for receiving and investigating whistleblower reports. It's crucial that this body maintains no affiliations with sports organizations to eliminate potential conflicts of interest. Clear Reporting Channels are necessary for enhancing accessibility, which includes setting up a variety of avenues such as online platforms, hotlines, and dedicated email addresses that facilitate the reporting process for whistleblowers. Providing Expert Support is equally essential, granting whistleblowers access to legal and psychological assistance to help them navigate potential emotional distress or legal challenges stemming from their actions. Introducing a Rewards System could serve as an incentive, offering financial rewards or protection against sanctions for whistleblowers who provide crucial information, even if they themselves were involved in doping. Educational efforts encompass Training and Awareness, targeting athletes, coaches, and other stakeholders to emphasize the significance of whistleblowing, elucidate the protections in place, and elucidate the process for reporting doping violations. Prompt Investigations are integral in preserving the system's credibility. Each whistleblower report should be swiftly and comprehensively investigated. Building Public Trust involves regularly communicating the successes achieved through the whistleblower mechanism. This not only bolsters confidence in the process but also acts as a deterrent to potential wrongdoers. Transparency is key throughout the investigative process, balancing openness with the need to respect the whistleblower's anonymity. This practice showcases the thoroughness and seriousness with which reports are treated. A system of Oversight and Accountability must be established to continually assess the effectiveness of the whistleblower framework and institute necessary refinements over time. This iterative process ensures its long-term viability and impact.

9.5. Encompassing the Entire Sporting Spectrum

It is imperative that the legislative framework extends its reach beyond the confines of high-profile sports and transcends the boundaries of competitive tiers. Inclusive of disciplines ranging from the most celebrated to the lesser-known, and from the echelons of professionalism to the grassroots of amateurism, the legislation must cast a wide net. The rationale behind this expansiveness lies in the recognition that the scourge of doping, like an insidious undercurrent, can infiltrate even the most remote corners of sporting involvement. By casting its protective mantle over all sports and levels, the legislation stands as a beacon of equitable ethics. It ensures that athletes, regardless of their chosen endeavor or their standing on the competitive ladder, are provided with a level playing field that is devoid of the taint of performance-enhancing substances. This inclusivity is not merely a matter of bureaucratic necessity; it symbolizes a steadfast commitment to upholding the ideals of fair play, where victory is determined by skill, dedication, and passion, rather than by chemically-fueled shortcuts.

9.6. Mainstream Legislative Incorporation of “Boosting”

In the realm of para-sports, where resilience and determination converge in extraordinary displays of athletic prowess, the imperative to address the burgeoning threat of boosting—encompassing doping practices and strategies aimed at exploiting physical conditions such as spinal cord injury—assumes paramount significance. The call to include these practices, rooted in their potential for grave health risks such as Autonomic Dysreflexia, within the ambit of the main legislative framework governing para-sports stands not only as a protective measure against unfair advantages but also as a testament to the profound commitment to the health and equitable competition of para-athletes.

9.7. Fostering a Culture of Prevention

Beyond immediate relief, a holistic approach champions a culture of prevention—an ethos that endeavors to thwart injuries before they take root. The utilization of opioids, although offering respite from pain, can inadvertently perpetuate the cycle of injury by masking warning signs. By prioritizing preventive measures such as proper training techniques, personalized conditioning, and mindful recovery, athletes can proactively reduce the likelihood of injuries, thus circumventing the need for strong painkillers. An integral component of this evolution is the education of athletes themselves. Empowering athletes with knowledge about the potential dangers of opioids and the interconnected risks of doping fosters a sense of agency over their own health. Understanding that the choices they make today can reverberate in their athletic careers and personal lives, athletes are more likely to gravitate toward alternatives that align with their long-term goals. The tapestry of holistic pain management is woven with an array of approaches that extend beyond the confines of traditional medicine. Integrative techniques, including physical therapy, acupuncture, massage, and mindfulness practices, are gaining prominence as viable alternatives to opioids. These approaches offer multifaceted benefits, from reducing pain and inflammation to enhancing mental resilience—rendering them instrumental in not only pain management, but also in bolstering overall athletic performance.

10. CONCLUSION

This paper underscores that combatting doping requires a multifaceted approach that combines legal rigor, medical understanding, and strategic ingenuity. By addressing the legal framework, exploring the interface between injuries and doping, and proposing pragmatic strategies, this paper contributes to the ongoing discourse on safeguarding the integrity of sports. Only through sustained collaborative efforts, driven by a commitment to uphold the spirit of competition, can the global sports community effectively curtail the scourge of doping and uphold the values that underpin the world of athletics.

BIBLIOGRAPHY